|
Krevní obraz - základní | Leukocyty | x109/l | | 0 hod | 9,0 – 30,0 | | 12 hod | 13,0 - 38 | | 24 hod | 9,4 – 34,0 | | 2 -7 D | 5,0 – 21,0 | | 8 -14 D | 5,0 – 20,0 | | 15D – 6M | 5,0 – 19,5 | | 6M– 2R | 6,0 – 17,5 | | 2 – 4 R | 5,5 – 17,0 | | 4 – 6 R | 6,0 – 15,5 | |
6 – 8 R | 4,5 – 14,5 | |
8 – 15 R | 4,5 – 13,5 | |
nad 15 let ženy | 4,0 – 10,0 | | nad 15 let muži | 4,0 – 10,0 | | erytrocyty | x1012/l | Hemoglobin | g/l | |
0 – 3D | 4,0 – 6,6 | 0 – 3D | 145 -225 | | 4D –
2T | 3,9 – 6,3 | 4D –
2T | 135 – 215 | | 2T –
1M | 3,6 – 6,2 | 2T –
1M | 125 – 205 | | 1M –
2M | 3,0 – 5,0 | 1M –
2M | 100 – 180 | | 2M –
3M | 2,7 – 4,9 | 2M –
3M | 90 – 140 | | 3M –
6M | 3,1 -4,5 | 3M –
6M | 95 – 135 | | 6M –
2R | 3,7 – 5,3 | 6M –
2R | 105 – 135 | | 2R –
6R | 3,9 -5,3 | 2R –
6R | 115 – 135 | | 6R –
12R | 4,0 -5,2 | 6R –
12R | 115 – 155 | | 12R –
15R ženy |
4,1 – 5,1 | 12R –
15R ženy |
120 - 160 | | 12R –
15R muži |
4,5 – 5,3 | 12R –
15R muži |
130 - 160 | | nad 15 let ženy | 3,8 –
5,2 | nad 15 let ženy | 120 –
160 | | nad 15 let muži | 4,0 –
5,8 | nad 15 let muži | 135 -
175 |
| hematokrit | % | MCV | fl | |
0 – 3D | 45,0 – 67,0 | 0 – 3D | 95,0 – 121,0 | | 4D –
2T | 42,0 – 66,0 | 4D –
2T | 88,0 – 126,0 | | 2T –
1M | 39,0 – 63,0 | 2T –
1M | 86,0 – 124,0 | | 1M –
2M | 31,0 – 55,0 | 1M –
2M | 85,0 – 123,0 | | 2M –
3M | 28,0 – 42,0 | 2M –
3M | 77,0 – 115,0 | | 3M –
6M | 29,0 – 41,0 | 3M –
6M | 74,0 – 108,0 | | 6M –
2R | 33,0 – 39,0 | 6M –
2R | 70,0 – 86,0 | | 2R –
6R | 34,0 – 40,0 | 2R –
6R | 75,0 – 87,0 | | 6R –
12R | 35,0 – 45,0 | 6R –
12R | 77,0 – 95,0 | | 12R –
15R ženy |
36,0 – 46,0 | 12R –
15R ženy |
78,0 – 102,0 | | 12R –
15R muži |
37,0 – 49,0 | 12R –
15R muži |
78,0 – 98,0 | | nad 15 let ženy | 35,0 –
47,0 | nad 15 let | 82,0 –
98,0 | | nad 15 let muži | 40,0 –
50,0 | | | | MCH | pg | MCHC | kg/l | |
0 – 3D | 31,0 – 37,0 | 0 – 3D | 290 – 370 | | 4D – 2M | 28,0 – 40,0 | 4D – 1M | 280 – 380 | | 2M – 3M | 26,0 – 34,0 | 1M – 3M | 290 – 370 | | 3M – 6M | 25,0 – 35,0 | 3M – 2R | 300 – 360 | | 6M – 2R | 23,0 – 31,0 | 2R – 15R | 310 – 370 | | 2R – 6R | 24,0 – 30,0 | nad 15 let | 320 – 360 | | 6R – 12R | 25,0 – 33,0 | | | | 12R – 15R | 25,0 – 35,0 | | | | nad 15 let | 28,0 – 34,0 | | | | trombocyty | x109/l | RDW | % | |
0 - 150 | 150 - 400 | 0 – 15R | 11,5 – 14,5 | | | | nad 15
let | 10,0 – 15,2 | | MPV | fl |
| nad 15 let | 7,8 – 12,8 | | NSER | % | x109/l | LYMR | % | x109/l | | nad 15 let | 45,0 –
70,0 | 2,0 – 7,0 | nad 15
let | 20,0 –
45,0 | 0,8 – 4,0 | | MONR | % | x109/l | EOSR | % | x109/l | | nad 15 let | 2,0
-12,0 | 0,08 – 1,2 | nad 15
let | 0 – 5,0 | 0,0 –
0,5 | | BASR | % | x109/l | | nad 15 let | 0 –
2,0 | 0,0 – 0,2 | | Normoblasty (NRBC) | % | x109/l | | 0 – 3D | 0 – 8,3 | 0 – 1,3 | | nad 4D | 0 | 0 | | nad 15 let | 0 –
0,1 | 0 – 0,015 | Zdroj referenčních hodnot
Referenční meze nastaveny dle doporučení České hematologické společnosti ČSL JEP
|